State Street Corp Annovis Bio, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Annovis Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 29,135 shares of ANVS stock, worth $161,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,135
Previous 23,535
23.79%
Holding current value
$161,990
Previous $440,000
21.36%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANVS
# of Institutions
52Shares Held
1.2MCall Options Held
779KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA358KShares$1.99 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA250KShares$1.39 Million0.01% of portfolio
-
Black Rock Inc. New York, NY97.6KShares$542,8170.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA72.6KShares$403,6670.0% of portfolio
-
Geode Capital Management, LLC Boston, MA70.8KShares$393,5970.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $45.4M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...